Your browser doesn't support javascript.
loading
Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells.
Wei, Zhenyu; Xu, Jiayu; Zhao, Chengkui; Zhang, Min; Xu, Nan; Kang, Liqing; Lou, Xiaoyan; Yu, Lei; Feng, Weixing.
Affiliation
  • Wei Z; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
  • Xu J; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
  • Zhao C; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
  • Zhang M; Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
  • Xu N; Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
  • Kang L; Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
  • Lou X; School of Chemical and Molecular Engineering, East China Normal University, Shanghai, China.
  • Yu L; Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
  • Feng W; School of Chemical and Molecular Engineering, East China Normal University, Shanghai, China.
Front Immunol ; 14: 1273507, 2023.
Article in En | MEDLINE | ID: mdl-37854590

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Burkitt Lymphoma / Receptors, Chimeric Antigen Limits: Adult / Child / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Burkitt Lymphoma / Receptors, Chimeric Antigen Limits: Adult / Child / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland